Cencora Inc
CORView Detailed Chart
286.930USD
+2.490+0.87%
Close 04/17, 16:00（ET）Quotes delayed by 15 min
55.62BMarket Cap
39.84P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.87%
5 Days
+0.93%
1 Month
+8.62%
6 Months
+20.84%
Year to Date
+27.70%
1 Year
+20.91%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
18
analysts
BUY
Current Rating
297.309
Target Price
3.69%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
111
Total
7
Median
9
Average
Company name
Ratings
Analysts
Cencora Inc
COR
18
Medtronic PLC
MDT
34
Stryker Corp
SYK
33
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
28
Dexcom Inc
DXCM
26
1
2
3
...
22
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Buy
Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.113
Buy
RSI(14)
68.862
Neutral
STOCH(KDJ)(9,3,3)
75.682
Buy
ATR(14)
8.564
High Vlolatility
CCI(14)
82.690
Neutral
Williams %R
33.879
Buy
TRIX(12,20)
0.355
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Indicators
Value
Direction
MA5
284.857
Buy
MA10
280.494
Buy
MA20
277.664
Buy
MA50
262.170
Buy
MA100
251.135
Buy
MA200
242.044
Buy
News
More news coming soon, stay tuned...
Company
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Company codeCOR
CompanyCencora Inc
CEODr. Robert P. (Bob) Mauch, Ph.D.
Websitehttps://www.cencora.com/
